Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

The interaction of polymorphisms of IL10 and DBH was associated with general symptoms of PANSS with TD in Chinese Han schizophrenic patients.

Sun H, Wang F, Fan H, Yan Q, Cui K, Yuan W, Zhao F, Zhao L, Yuan J, Yang F, Kosten TR, Zhang XY.

PLoS One. 2013 Aug 7;8(8):e70963. doi: 10.1371/journal.pone.0070963. eCollection 2013.

PMID:
23951054
[PubMed - in process]
Free PMC Article
2.

Association between TNF-α promoter -308A/G polymorphism and tardive dyskinesian Chinese Han patients with schizophrenia.

Wang F, Fan H, Sun H, Yang F, Luo Y, Liu H, Kosten TR, Lu L, Zhang XY.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):106-10. doi: 10.1016/j.pnpbp.2011.12.007. Epub 2011 Dec 29.

PMID:
22227290
[PubMed - indexed for MEDLINE]
3.

Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients.

Liu H, Wang C, Chen PH, Zhang BS, Zheng YL, Zhang CX, Meng HQ, Wang Y, Chen da C, Xiu MH, Kosten TR, Zhang XY.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):692-6. doi: 10.1016/j.pnpbp.2010.03.026. Epub 2010 Mar 25.

PMID:
20346996
[PubMed - indexed for MEDLINE]
4.

Association of the dopamine β-hydroxylase 19 bp insertion/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia.

Zhou N, Yu Q, Li X, Yu Y, Kou C, Li W, Xu H, Luo X, Zuo L, Kosten TR, Zhang XY.

Hum Psychopharmacol. 2013 May;28(3):230-7. doi: 10.1002/hup.2311. Epub 2013 Apr 5.

PMID:
23559427
[PubMed - indexed for MEDLINE]
5.

Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.

Liou YJ, Wang YC, Chen JY, Bai YM, Lin CC, Liao DL, Chen TT, Chen ML, Mo GH, Lai IC.

Psychiatry Res. 2007 Dec 3;153(3):271-5. Epub 2007 Jul 31.

PMID:
17669510
[PubMed - indexed for MEDLINE]
6.
7.

Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.

Tan YL, Zhou DF, Zhang XY.

Schizophr Res. 2005 May 1;74(2-3):263-70.

PMID:
15722005
[PubMed - indexed for MEDLINE]
8.

White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study.

Bai YM, Chou KH, Lin CP, Chen IY, Li CT, Yang KC, Chou YH, Su TP.

Schizophr Res. 2009 Apr;109(1-3):167-81. doi: 10.1016/j.schres.2009.02.003. Epub 2009 Mar 3.

PMID:
19261444
[PubMed - indexed for MEDLINE]
9.

Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.

Fu Y, Fan CH, Deng HH, Hu SH, Lv DP, Li LH, Wang JJ, Lu XQ.

Acta Pharmacol Sin. 2006 Mar;27(3):328-32.

PMID:
16490169
[PubMed - indexed for MEDLINE]
Free Article
10.

Reduced serum TNF alpha level in chronic schizophrenia patients with or without tardive dyskinesia.

Tian L, Tan Y, Chen D, Lv M, Tan S, Soares JC, Zhang XY.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 2;54C:259-264. doi: 10.1016/j.pnpbp.2014.06.012. [Epub ahead of print]

PMID:
24995685
[PubMed - as supplied by publisher]
11.

[Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].

Zhang Z, Hou G, Zhang X, Yao H, Sha W, Zhang X.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Apr;20(2):98-102. Chinese.

PMID:
12673575
[PubMed - indexed for MEDLINE]
12.

Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia.

Zhang XY, Chen da C, Qi LY, Wang F, Xiu MH, Chen S, Wu GY, Kosten TA, Kosten TR.

Psychopharmacology (Berl). 2009 Sep;205(4):647-54. doi: 10.1007/s00213-009-1590-8. Epub 2009 Jun 16.

PMID:
19529921
[PubMed - indexed for MEDLINE]
13.

Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.

Woo SI, Kim JW, Rha E, Han SH, Hahn KH, Park CS, Sohn JW.

Psychiatry Clin Neurosci. 2002 Aug;56(4):469-74.

PMID:
12109967
[PubMed - indexed for MEDLINE]
14.

Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.

Zhang XY, Zhou DF, Cao LY, Chen DC, Zhu FY, Wu GY.

Schizophr Res. 2003 Aug 1;62(3):245-50.

PMID:
12837521
[PubMed - indexed for MEDLINE]
15.

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.

Zai CC, Hwang RW, De Luca V, Müller DJ, King N, Zai GC, Remington G, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL.

Int J Neuropsychopharmacol. 2007 Oct;10(5):639-51. Epub 2006 Sep 7.

PMID:
16959057
[PubMed - indexed for MEDLINE]
16.

Smoking and tardive dyskinesia in male patients with chronic schizophrenia.

Zhang XY, Yu YQ, Sun S, Zhang X, Li W, Xiu MH, Chen da C, Yang FD, Zhu F, Kosten TA, Kosten TR.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1765-9. doi: 10.1016/j.pnpbp.2011.06.006. Epub 2011 Jun 23.

PMID:
21723906
[PubMed - indexed for MEDLINE]
17.

Cytochrome P-450 2D6*10 C188T polymorphism is associated with antipsychotic-induced persistent tardive dyskinesia in Chinese schizophrenic patients.

Liou YJ, Wang YC, Bai YM, Lin CC, Yu SC, Liao DL, Lin MW, Chen JY, Lai IC.

Neuropsychobiology. 2004;49(4):167-73.

PMID:
15118351
[PubMed - indexed for MEDLINE]
18.

Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia.

Park SW, Lee JG, Kong BG, Lee SJ, Lee CH, Kim JI, Kim YH.

Psychiatry Clin Neurosci. 2009 Aug;63(4):433-9. doi: 10.1111/j.1440-1819.2009.01976.x. Epub 2009 Apr 27.

PMID:
19457211
[PubMed - indexed for MEDLINE]
19.

Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods.

Kinon BJ, Jeste DV, Kollack-Walker S, Stauffer V, Liu-Seifert H.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Sep;28(6):985-96.

PMID:
15380859
[PubMed - indexed for MEDLINE]
20.

Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.

Reynolds GP, Yao Z, Zhang X, Sun J, Zhang Z.

Eur Neuropsychopharmacol. 2005 Mar;15(2):143-51.

PMID:
15695058
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk